Interestingly, CTCs-negative breast cancer samples had increased level of CDH2 in comparison to CTCs-positive samples (average expression 31.31 vs. 19.53, respectively; p = 0.020; Figure S1). This evidence concerns the gene CDH2 and breast carcinoma.